Literature DB >> 20075404

Primary immunodeficiency diseases: a practical guide for clinicians.

S E Turvey1, F A Bonilla, A K Junker.   

Abstract

Primary immunodeficiency diseases (PIDs) are genetically determined disorders of the immune system resulting in greatly enhanced susceptibility to infectious disease, autoimmunity and malignancy. While individual PIDs are rare, as a group, it is estimated that between 1:2000 and 1:10 000 live births are affected by a PID. Moreover, PIDs can present at any age from birth to adulthood, posing a considerable challenge for the practising physician to know when and how to work-up a patient for a possible immune defect. In this review, we outline the basic organisation of the human immune system and the types of infections that occur when elements of the immune system are dysfunctional. Importantly, we provide practical guidelines for identifying patients who should be referred for assessment of possible immunodeficiency and an overview of screening investigations and effective therapeutic options available for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 20075404     DOI: 10.1136/pgmj.2009.080630

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  10 in total

1.  Lymphoma Secondary to Congenital and Acquired Immunodeficiency Syndromes at a Turkish Pediatric Oncology Center.

Authors:  Hikmet G Tanyildiz; Handan Dincaslan; Gulsan Yavuz; Emel Unal; Aydan Ikinciogulları; Figen Dogu; Nurdan Tacyildiz
Journal:  J Clin Immunol       Date:  2016-08-04       Impact factor: 8.317

2.  2B4-SAP signaling is required for the priming of naive CD8+ T cells by antigen-expressing B cells and B lymphoma cells.

Authors:  Yu-Hsuan Huang; Kevin Tsai; Sara Y Tan; Sohyeong Kang; Mandy L Ford; Kenneth W Harder; John J Priatel
Journal:  Oncoimmunology       Date:  2016-12-27       Impact factor: 8.110

3.  Clinical Pearls in pediatric infections.

Authors:  Sunit Singhi; Joseph Mathew; Atul Jindal; Sanjay Verma
Journal:  Indian J Pediatr       Date:  2011-05-28       Impact factor: 1.967

Review 4.  How reliable is online diffusion of medical information targeting patients and families?

Authors:  Pedro Xavier-Elsas; Sandra Epifânio Bastos; Maria Ignez C Gaspar-Elsas
Journal:  World J Exp Med       Date:  2015-11-20

Review 5.  Autoimmunity in immunodeficiency.

Authors:  Krista Todoric; Jessica B Koontz; Daniel Mattox; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

Review 6.  Primary immunodeficiency for the primary care provider.

Authors:  A W O'Keefe; M Halbrich; M Ben-Shoshan; C McCusker
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

7.  Economic benefits of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency.

Authors:  A Martin; L Lavoie; M Goetghebeur; R Schellenberg
Journal:  Transfus Med       Date:  2012-11-20       Impact factor: 2.057

Review 8.  Towards the targeted management of Chediak-Higashi syndrome.

Authors:  Maria L Lozano; Jose Rivera; Isabel Sánchez-Guiu; Vicente Vicente
Journal:  Orphanet J Rare Dis       Date:  2014-08-18       Impact factor: 4.123

9.  Medical awareness concerning primary immunodeficiency diseases in the city of São Paulo, Brazil.

Authors:  Ellen de Oliveira Dantas; Carolina Sanchez Aranda; Fernanda Aimée Nobre; Kristine Fahl; Juliana Themudo Lessa Mazzucchelli; Erika Felix; Dora Lisa Friedlander-Del Nero; Victor Nudelman; Flavio Sano; Antonio Condino-Neto; Elaine Damasceno; Beatriz Tavares Costa-Carvalho
Journal:  Einstein (Sao Paulo)       Date:  2013-12

10.  Inborn Errors of Immunity Associated With Type 2 Inflammation in the USIDNET Registry.

Authors:  Kelsey L Smith; Darlene Dai; Bhavi P Modi; Rahnuma Sara; Elizabeth Garabedian; Rebecca A Marsh; Jennifer Puck; Elizabeth Secord; Kathleen E Sullivan; Stuart E Turvey; Catherine M Biggs
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.